3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck

J. Bourhis, X. Sun, C. Le Tourneau, Y. Pointreau, C. Sire, et al.. 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck. Annals of Oncology, Elsevier, 2020, 31 (4), pp.S1168. ⟨10.1016/j.annonc.2020.08.2269⟩. ⟨hal-03600472⟩